Peregrine Pharmaceuticals announced that it is changing its name to Avid Bioservices as part of its transition to a contract development and manufacturing organization (CDMO).    The company is still focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.   “As our organization transitions to a pure play CDMO, we believe it is appropriate to take advantage of the brand recognition that has been built within this highly spec...